Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxipost Headache Induction and Hemodynamics
NCT03887325Phase 1Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Apr 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Flindokalner (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Occurrence and change of migraine attack. Started Apr 2019; status: completed.
02
Drugs
Flindokalner
Beyond the preview
Go deeper on NCT03887325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887325.